ralfinamide (NW-1029) / Newron  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ralfinamide (NW-1029) / Newron
NCT00736151 / 2004-000557-35: Phase II Dose Titration Study in Patients With Neuropathic Pain

Completed
2
272
Europe, RoW
Ralfinamide
Newron Pharmaceuticals SPA
Neuropathic Pain
04/07
 

Download Options